Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Colorectal Acf Screening. Regression. and P-261005125
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Toxicant disruption of receptor-mediated endocytosis in oogenesis and later life metabolic dysfunction
Phase 2 of a 3-phase 1-GHz LTS/HTS NMR Magnet
Specificity of DNA Repair for Oxidized Abasic Sites
Three Dimensional Reconstruction of Synapses
Immunophysiology of Keratinocyte Cytokines
Recently added grants:
Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages
Administrative Core: U19
Using siglecs and their ligands to treat allergic diseases SALTAD
Data Management and Bioinformatics Core
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005125-001
Application #
6994810
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2004
N01 CN
Phase II Clinical Trial of Colorectal Acf Screening. Regression. and P-261005125
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Colorectal Acf Screening, Reg
Sinicrope, Frank / University of Texas MD Anderson Cancer Center
$1,136,114
Comments
Be the first to comment on this grant